These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16129253)

  • 1. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions.
    Böhm I; Speck U; Schild H
    Eur J Radiol; 2005 Sep; 55(3):431-6. PubMed ID: 16129253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I; Speck U; Schild H
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study on basophil activation induced by contrast medium.
    Böhm I; Speck U; Schild HH
    Fundam Clin Pharmacol; 2011 Apr; 25(2):267-76. PubMed ID: 20412314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profiles after nonionic dimeric contrast medium injection.
    Böhm I; Speck U; Schild H
    Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed adverse reactions to iodinated contrast media and their risk factors.
    Hosoya T; Yamaguchi K; Akutsu T; Mitsuhashi Y; Kondo S; Sugai Y; Adachi M
    Radiat Med; 2000; 18(1):39-45. PubMed ID: 10852654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
    Schmiedel E
    Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe reactions to iodinated contrast agents: is anaphylaxis responsible?].
    Dewachter P; Mouton-Faivre C
    J Radiol; 2001 Sep; 82(9 Pt 1):973-7. PubMed ID: 11591924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse skin reactions to iodinated x-ray contrast agents in healthy rats.
    Lenhard DC; May E; Morgenroth C; Jost G; Haider W; Pietsch H
    Invest Radiol; 2014 Dec; 49(12):779-87. PubMed ID: 24988006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed vs. immediate adverse reactions to ionic and non-ionic low-osmolality contrast media.
    Oi H; Yamazaki H; Matsushita M
    Radiat Med; 1997; 15(1):23-7. PubMed ID: 9134581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial.
    Schild HH; Kuhl CK; Hübner-Steiner U; Böhm I; Speck U
    Radiology; 2006 Jul; 240(1):56-64. PubMed ID: 16720865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy?
    Trcka J; Schmidt C; Seitz CS; Bröcker EB; Gross GE; Trautmann A
    AJR Am J Roentgenol; 2008 Mar; 190(3):666-70. PubMed ID: 18287437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic basis for adverse reactions to radiographic contrast media.
    Stejskal V; Nilsson R; Grepe A
    Acta Radiol; 1990 Nov; 31(6):605-12. PubMed ID: 2278787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy].
    Kondo K; Kamidono S; Hamami G
    Hinyokika Kiyo; 1988 Oct; 34(10):1845-51. PubMed ID: 3245531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions and contrast medium injection: are they always related?
    Böhm I; Alfke H; Klose KJ
    Eur J Radiol; 2011 Nov; 80(2):368-72. PubMed ID: 21251786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.
    Wendt-Nordahl G; Rotert H; Trojan L; Michel MS; Peters CR; Alken P; Knoll T
    Med Princ Pract; 2006; 15(5):358-61. PubMed ID: 16888393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging.
    Rossi C; Reginelli A; D'Amora M; Di Grezia G; Mandato Y; D'Andrea A; Brunese L; Grassi R; Rotondi A
    J Biol Regul Homeost Agents; 2014; 28(1):155-65. PubMed ID: 24750802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergy-like reactions to iodinated contrast agents. A critical analysis.
    Idée JM; Pinès E; Prigent P; Corot C
    Fundam Clin Pharmacol; 2005 Jun; 19(3):263-81. PubMed ID: 15910651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral intravenous power injection of iodinated contrast media through 22G and 20G cannulas: can high flow rates be achieved safely? A clinical feasibility study.
    Schwab SA; Uder M; Anders K; Heinrich MC; Kuefner MA
    Rofo; 2009 Apr; 181(4):355-61. PubMed ID: 19280548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl-leukotrienes in nasal lavage fluid in children with asthma.
    Singer F; Horak F; Friesenbichler W; Schneider B; Szépfalusi Z; Frischer T
    Pediatr Allergy Immunol; 2008 May; 19(3):227-32. PubMed ID: 18397406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.